Position in MRNA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$721,969
+$302,858 QoQ
Shares Held
14,212
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MUFG Securities EMEA plc holds $31,265,233 across 8 Biotechnology names. MRNA ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,132 | $13,236,868 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
200,000 | $5,540,000 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
49,043 | $4,769,431 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,413 | $4,649,821 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
145,000 | $1,365,900 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
14,212 | $721,969 | |
| 7 | INCY |
Incyte Corp
|
6,853 | $645,004 | |
| 8 | TECH |
BIO-TECHNE Corp
|
6,434 | $336,240 |
All Filings in MRNA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $721,969 | 14,212 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $419,111 | 14,212 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $171,201 | 6,628 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,534 | 998 | Shares | Sole | 2025-10-07 | |
| No filing history on record for this holder in this stock. | ||||||